# A proof-of Concept, Randomized 3-month Study to Evaluate the Effects of Three Contraceptive Intrauterine Systems Delivering Copper and a Daily Dose of 5, 20 or 40 μg of Ulipristal Acetate (UPA)

> **NCT03230539** · PHASE1 · UNKNOWN · sponsor: **Population Council** · enrollment: 30 (estimated)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** Ulipristal Acetate IUS delivering Cu and 5μg
- **DRUG:** Ulipristal Acetate IUS delivering Cu and 20μg
- **DRUG:** Ulipristal Acetate IUS delivering Cu and 40μg

## Key facts

- **NCT ID:** NCT03230539
- **Lead sponsor:** Population Council
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-01
- **Primary completion:** 2018-01
- **Final completion:** 2018-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03230539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03230539, "A proof-of Concept, Randomized 3-month Study to Evaluate the Effects of Three Contraceptive Intrauterine Systems Delivering Copper and a Daily Dose of 5, 20 or 40 μg of Ulipristal Acetate (UPA)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03230539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*